Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-06 Sale | 2024-03-07 4:27 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer | 77,550 | $13.52 | $1,048,119 | 225,081 (Direct) | View |
| 2024-03-05 Sale | 2024-03-07 4:20 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 48,629 | $13.52 | $657,240 | 121,519 (Direct) | View |
| 2024-03-05 Sale | 2024-03-07 4:16 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Conway Vikki L See "Remarks" | 1,427 | $13.52 | $19,286 | 20,176 (Direct) | View |
| 2024-03-05 Sale | 2024-03-07 4:12 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark EVP, International Markets | 100,000 | $13.52 | $1,352,090 | 406,355 (Direct) | View |
| 2024-03-04 Sale | 2024-03-05 4:39 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Conway Vikki L See "Remarks" | 3,532 | $13.37 | $47,234 | 74,949 (Direct) | View |
| 2024-03-04 Sale | 2024-03-05 4:27 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO | 31,061 | $13.34 | $414,270 | 525,880 (Direct) | View |
| 2024-03-04 Sale | 2024-03-05 4:21 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 95,762 | $13.34 | $1,277,207 | 405,392 (Direct) | View |
| 2024-03-04 Sale | 2024-03-05 4:16 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" | 8,045 | $13.34 | $107,299 | 184,561 (Direct) | View |
| 2024-02-28 Sale | 2024-03-01 06:45 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations | 9,815 | $13.12 | $128,734 | 9,701 (Direct) | View |
| 2024-02-28 Sale | 2024-03-01 06:43 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 20,599 | $13.12 | $270,176 | 69,770 (Direct) | View |
| 2024-02-28 Sale | 2024-03-01 06:40 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Conway Vikki L See "Remarks" | 1,366 | $13.12 | $17,916 | 2,928 (Direct) | View |
| 2024-02-16 Sale | 2024-02-21 07:37 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations | 173,261 | $13.05 | $2,261,905 | 1 (Direct) | View |
| 2024-02-15 Sale | 2024-02-20 07:42 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO | 74,530 | $13.15 | $980,174 | 410,436 (Direct) | View |
| 2024-02-01 Sale | 2024-02-05 07:49 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer | 31,766 | $12.37 | $392,955 | 10,676 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-05 Exercise | 2024-03-07 4:27 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer | 73,707 | $0 | 225,081 (Direct) | View |
| 2024-03-05 Exercise | 2024-03-07 4:24 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations | 77,802 | $0 | 168,491 (Direct) | View |
| 2024-03-05 Exercise | 2024-03-07 4:20 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 77,802 | $0 | 121,519 (Direct) | View |
| 2024-03-05 Exercise | 2024-03-07 4:16 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Conway Vikki L See "Remarks" | 4,954 | $0 | 20,176 (Direct) | View |
| 2024-03-05 Exercise | 2024-03-07 4:12 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark EVP, International Markets | 81,897 | $0 | 406,355 (Direct) | View |
| 2024-03-05 Exercise | 2024-03-07 4:08 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer | 3,564 | $0 | 36,880 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-05 4:46 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | McAvoy David R. EVP, Chief Legal Officer | 66,964 | $0 | 66,964 (Direct) | View |
| 2024-03-03 Exercise | 2024-03-05 4:39 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Conway Vikki L See "Remarks" | 12,296 | $0 | 74,949 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-05 4:39 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Conway Vikki L See "Remarks" | 33,482 | $0 | 74,949 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-05 4:35 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fox Christine EVP, Head of U.S. Commercial | 81,845 | $0 | 81,845 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-05 4:30 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Grant Angus EVP, Business Development | 52,083 | $0 | 52,083 (Direct) | View |
| 2024-03-03 Exercise | 2024-03-05 4:27 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO | 67,231 | $0 | 525,880 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-05 4:27 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO | 200,892 | $0 | 525,880 (Direct) | View |
| 2024-03-03 Exercise | 2024-03-05 4:25 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations | 58,412 | $0 | 219,653 (Direct) | View |
| 2024-03-03 Exercise | 2024-03-05 4:21 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 95,762 | $0 | 405,392 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-05 4:21 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 81,845 | $0 | 405,392 (Direct) | View |
| 2024-03-03 Exercise | 2024-03-05 4:16 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" | 24,900 | $0 | 184,561 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-05 4:16 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" | 93,005 | $0 | 184,561 (Direct) | View |
| 2024-03-03 Exercise | 2024-03-05 4:12 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark EVP, International Markets | 58,412 | $0 | 616,822 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-05 4:12 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark EVP, International Markets | 74,404 | $0 | 616,822 (Direct) | View |
| 2024-03-03 Exercise | 2024-03-05 4:08 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer | 83,312 | $0 | 682,095 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-05 4:08 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer | 93,005 | $0 | 682,095 (Direct) | View |
| 2024-03-03 Exercise | 2024-03-05 4:03 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer | 15,855 | $0 | 89,243 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-05 4:03 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer | 22,600 | $0 | 89,243 (Direct) | View |
| 2024-02-28 Exercise | 2024-03-01 06:57 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Bergwerk Dov Acting Chief Legal Officer | 6,653 | $0 | 96,983 (Direct) | View |
| 2024-02-28 Exercise | 2024-03-01 06:54 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer | 18,430 | $0 | 124,222 (Direct) | View |
| 2024-02-28 Exercise | 2024-03-01 06:52 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark EVP, International Markets | 20,599 | $0 | 342,281 (Direct) | View |
| 2024-02-28 Exercise | 2024-03-01 06:48 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer | 3,219 | $0 | 13,895 (Direct) | View |
| 2024-02-28 Exercise | 2024-03-01 06:45 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations | 19,515 | $0 | 9,701 (Direct) | View |
| 2024-02-28 Exercise | 2024-03-01 06:43 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 20,599 | $0 | 69,770 (Direct) | View |
| 2024-02-28 Exercise | 2024-03-01 06:40 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Conway Vikki L See "Remarks" | 4,294 | $0 | 2,928 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-20 07:42 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO | 161,655 | $0 | 410,436 (Direct) | View |
| 2024-02-13 Exercise | 2024-02-15 07:37 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer | 6,630 | $0 | 105,792 (Direct) | View |
| 2024-01-30 Option Award | 2024-02-01 07:28 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 55,226 | $0 | 55,226 (Direct) | View |
| 2024-01-30 Option Award | 2024-02-01 07:26 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer | 52,320 | $0 | 52,320 (Direct) | View |
| 2024-01-30 Option Award | 2024-02-01 07:22 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations | 55,226 | $0 | 55,226 (Direct) | View |
| 2024-01-30 Option Award | 2024-02-01 07:18 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark EVP, International Markets | 58,133 | $0 | 58,133 (Direct) | View |
| 2023-11-20 Option Award | 2023-11-22 07:18 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fox Christine EVP, Head of U.S. Commercial | 253,968 | $0 | 253,968 (Direct) | View |
| 2023-11-15 Option Award | 2023-11-16 07:36 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Conway Vikki L See "Remarks" | 33,482 | $0 | 33,482 (Direct) | View |
| 2023-11-15 Option Award | 2023-11-16 07:35 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Bergwerk Dov Acting Chief Legal Officer | 33,482 | $0 | 33,482 (Direct) | View |
Ownership | 2023-10-18 07:15 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Bergwerk Dov Acting Chief Legal Officer | 0 | $0 | 268,460 (Direct) | View |
Ownership | 2023-10-05 07:20 am | N/A 2024-03-12 | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Conway Vikki L See "Remarks" | 0 | $0 | 114,628 (Direct) | View |
| 2023-09-02 Option Award | 2023-09-05 4:05 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shalev Varda Director | 12,872 | $0 | 12,872 (Direct) | View |